Friday, 27 June 2014

Global Molecular Cytogenetics Market 2014-2018

 Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand the role and functions of genes and chromosomes. It plays a crucial role in the early diagnosis of a disease, identification of genetic tendency to cause disease, and prediction of an individual’s reaction to drugs. The FISH and aCGH play a prominent role in molecular cytogenetics technology. It involves the screening and diagnostic tests that are used for determining the complex interaction of genes and chromosomes to assess the status of a disease. In addition, molecular cytogenetics is mainly used in the R&D activities of research laboratories for drug discovery, identification of biomarkers, and screening drug candidates that react to these biomarkers. Analysts forecast the Global Molecular Cytogenetics Market will grow at a CAGR of 23.51 percent over the period 2013-2018.

The Report recognizes the following companies as the key players in Global Molecular Cytogenetics Market : Abbott Laboratories , Affymetrix Inc. , Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., PerkinElmer Inc., Applied Spectral Imaging Ltd, Biological Industries Ltd, Bio-Rad Laboratories Inc., Cytognomix Inc., CytoTest Inc., Illumina Inc., Kreatech Inc. , Leica Biosystems Ltd, Life Technologies Corp., Oxford Gene Technology Ltd, SciGene Corp.

Molecular cytogenetic techniques can be used in personalized medicines for the early detection of diseases and selection of appropriate treatment, integration of molecular diagnostics with therapeutics, and monitoring therapy, as well as determining the prognosis. At present, cytogenetic analysis allows the study of essential biological problems such as the nature of inherited syndromes and genomic variations, which are responsible for carcinogenesis and 3D organization of the human genome. Identification and validation of the genetic composition of an individual plays a major part in ascertaining health and susceptibility to common diseases such as heart disease and cancer. The awareness of genetic diseases is helping in the development of personalized medicines, which are focused on targeted drug development. Genetic profiling of patients helps in defining an individual's risk for clinical outcomes and his/her response to specific drugs. Personalized medicines are highly effective and help improve the health of a patient.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Molecular Cytogenetics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used in molecular cytogenetics. The products employed in the use of FISH and aCGH techniques are considered within the

Scope of the report
Global Molecular Cytogenetics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Molecular Cytogenetics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.

According to the report, the increase in the incidence of genetic disorders is one of the major drivers. Genetic disorders such as Down syndrome, fragile X syndrome, tuberous sclerosis, and other genetic and chromosomal disorders have increased the demand for cytogenetic diagnostic kits and technology.

Further, the report states that one of the major challenges in the market is the lack of knowledge about genomics among doctors and researchers, which leads to misinterpretation of the genetic data of an individual.